Discover Editas Medicine's groundbreaking patent for enzymatically active Cas9 fusion molecules, enhancing gene editing precision with innovative nucleic acid applications.

The following is a summary of “Insights into the molecular alterations of PLAG1 and HMGA2 in the malignant phenotype ...

RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic ...

Japanese drugmaker Eisai closed down 2.3% at 5,587 yen today, despite news of regulatory approvals for two of its drugs.

Cryoport, Inc. ("Cryoport"), a global leader in supply chain solutions for the life sciences industry, and SK pharmteco, a global contract development and manufacturing organization, today announced a ...

RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic disorders and cancer due to ...

Armoury Data is one of the most important currencies in Warhammer 40,000: Space Marine 2. It is required to unlock the higher ...

A recent study from Flinders University in Australia has made a significant discovery that could change the way we understand ...

AZN's key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Farxiga are likely to drive sales. It has several candidates with blockbuster potential.

The winter season ushers in a new globally spreading COVID-19 variant called XEC, a mix of KS.1.1 and KP.3.3, both from the ...

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced that its mammalian cell line ...

David Cronenberg's body horror hit The Fly, starring an unhinged Jeff Goldblum, is coming to streaming next month. Find out ...